Culiacán

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Sjögren's disease2 trials
• Coronary artery disease1 trial
• Familial hypercholesterolaemia1 trial
• Hidradenitis suppurativa1 trial
• Osteoarthritis1 trial
• Stroke1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Active, not recruiting4 trials
• Terminated1 trial

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Active, not recruiting

  A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06840392· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

  NCT05985915· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

  NCT05349214· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Terminated

  Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

  NCT04864392· Phase 2· Novartis Pharmaceuticals· Source